Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-27T15:24:39.625Z Has data issue: false hasContentIssue false
  • English
  • Français

Soft tissue head and neck sarcoma: experience of a tertiary referral centre over a 15-year period

Published online by Cambridge University Press:  29 November 2019

L Harrison ,
T McCulloch  and
N Beasley
L Harrison*
Affiliation:
Department of Otorhinolaryngology, Head and Neck Surgery, Oxford University Hospitals, UK
T McCulloch
Affiliation:
Department of Histopathology, University Hospital, Nottingham, UK
N Beasley
Affiliation:
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital, Nottingham, UK
*
Author for correspondence: Ms Laura Harrison, Department of Otorhinolaryngology, Head and Neck Surgery, Oxford University Hospitals, Oxford, UK E-mail: lauraharrison707@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Head and neck soft tissue sarcoma is uncommon. It is both histologically and clinically heterogeneous, ranging from an indolent, locally destructive tumour, to a locally aggressive neoplasm with metastatic potential.

Methods

A retrospective review was conducted of all adult head and neck soft tissue sarcomas, including cases of malignant soft tissue sarcoma and all intermediate type tumours, diagnosed between 1997 and 2012.

Results

Sixty-eight cases were identified in this series from the sarcoma multidisciplinary team. Seventeen different histological subtypes of sarcoma were identified. Neither age, gender nor tumour size were significant prognostic indicators for survival in this series.

Conclusion

Prognosis is dependent on histological subtype, underscoring the importance of histological classification. Some histological subtypes occur only once or twice in a decade, even within a large regional referral centre. An accumulation of evidence from relatively small case series is key in the long-term development of treatment strategies.

Keywords

Sarcoma, Soft TissuePrognosisSurvivalWorld Health Organization
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 133 , Issue 12 , December 2019 , pp. 1053 - 1058
Copyright
Copyright © JLO (1984) Limited, 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Ms L Harrison takes responsibility for the integrity of the content of the paper

References

1Edge, SB, Byrd, DR, Compton, CC, Fritz, AG, Greene, FL, Trotti, A. AJCC Cancer Staging Manual, 7th edn. New York: Springer, 2010;291Google ScholarPubMed
2Zagars, GK, Ballo, MT, Pisters, PW, Pollock, RE, Patel, SR, Benjamin, RS et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1,225 patients. Cancer 2003;97:2530–43CrossRefGoogle Scholar
3Mattavelli, D, Miceli, R, Radaelli, S, Mattavelli, F, Cantù, G, Barisella, M et al. Head and neck soft tissue sarcomas: prognostic factors and outcome in a series of patents treated in a single institution. Ann Oncol 2013;24:2181–9CrossRefGoogle Scholar
4Fletcher, CDM, Bridge, JA, Hogendoorn, P, Mertens, F. WHO Classification of Tumours of Soft Tissue and Bone, 4th edn. Geneva: WHO Press, 2013;1Google Scholar
5Noujaim, J, Thway, K, Sheri, A, Keller, C, Jones, RL. Histology-driven therapy: the importance of diagnostic accuracy in guiding systemic therapy of soft tissue tumors. Int J Surg Pathol 2016;24:5–15CrossRefGoogle ScholarPubMed
6Guillou, L, Coindre, JM, Bonichon, F, Nguyen, BB, Terrier, T, Collin, F et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 1997;15:350–62CrossRefGoogle Scholar
7O'Neill, JP, Bilsky, MH, Kraus, D. Head and neck sarcomas epidemiology, pathology, and management. Neurosurg Clin N Am 2013;24:67–8CrossRefGoogle ScholarPubMed
8Brockstein, B. Management of sarcomas of the head and neck. Curr Oncol Rep 2004;6:321–7CrossRefGoogle ScholarPubMed
9Potter, BO, Sturgis, EM. Sarcomas of the head and neck. Surg Oncol Clin N Am 2003;12:379–417CrossRefGoogle ScholarPubMed
10Bentz, BG, Singh, B, Woodruff, J, Brennan, M, Shah, JP, Kraus, D. Head and neck soft tissue sarcomas: a multivariate analysis of outcomes. Ann Surg Oncol 2004;11:619–28CrossRefGoogle ScholarPubMed
11Park, JT, Roh, JL, Kim, SO, Cho, KJ, Choi, SH, Nam, SY et al. Prognostic factors and oncological outcomes of 122 head and neck soft tissue sarcoma patients treated at a single institution. Ann Surg Oncol 2015;22:248–55CrossRefGoogle Scholar
12Barker, JL, Paulino, AC, Feeney, S, McCulloch, T, Hoffman, H. Locoregional treatment for adult soft tissue sarcomas of the head and neck: an institutional review. Cancer J 2003;9:49–57CrossRefGoogle ScholarPubMed
13Colville, RJ, Charlton, F, Kelly, CG, Nicoll, JJ, McLean, NR. Multidisciplinary management of head and neck sarcomas. Head Neck 2005;27:814–24CrossRefGoogle ScholarPubMed
14Tejani, MA, Galloway, TJ, Lango, M, Ridge, JA, von Mehren, M. Head and neck sarcomas: a comprehensive cancer center experience. Cancers (Basel) 2013;5:890–900CrossRefGoogle ScholarPubMed
15Mücke, T, Mitchell, DA, Tannapfel, A, Hölzle, F, Kesting, MR, Wolff, KD et al. Outcome in adult patients with head and neck sarcomas--a 10-year analysis. J Surg Oncol 2010;102:170–4CrossRefGoogle ScholarPubMed
16González-González, R, Bologna-Molina, R, Molina-Frechero, N, Domínguez-Malagon, HR. Prognostic factors and treatment strategies for adult head and neck soft tissue sarcoma. Int J Oral Maxillofac Surg 2012;41:569–75CrossRefGoogle ScholarPubMed
17Kraus, DH, Dubner, S, Harrison, LB, Strong, EW, Hajdu, SI, Kher, U et al. Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas. Cancer 1994;74:697–7023.0.CO;2-A>CrossRefGoogle ScholarPubMed
18Dijkstra, MD, Balm, AJ, Coevorden, FV, Gregor, RT, Hart, AA, Hilgers, FJ et al. Survival of adult patients with head and neck soft tissue sarcomas. Clin Otolaryngol 1996;21:66–71CrossRefGoogle ScholarPubMed
19Willers, H, Hug, EB, Spiro, IJ, Efird, JT, Rosenberg, AE, Wang, CC. Adult soft tissue sarcomas of the head and neck treated by radiation and surgery or radiation alone: patterns of failure and prognostic factors. Int J Radiat Oncol 1995;33:585–93CrossRefGoogle ScholarPubMed
20Penel, N, Mallet, YM, Robin, C, Fournier, C, Grosjean, J, Ceugnart, L et al. Prognostic factors for adult sarcomas of head and neck. Int J Oral Maxillofac Surg 2008;37:428–32CrossRefGoogle ScholarPubMed
21Greager, JA, Patel, MK, Briele, HA, Walker, MJ, Das Gupta, TK. Soft tissue sarcomas of the head and neck. Cancer 1985;56:820–43.0.CO;2-P>CrossRefGoogle ScholarPubMed
22Change, AE, Chai, X, Pollack, SM, Loggers, E, Rodler, E, Dillon, J et al. Analysis of clinical prognostic factors for adult patients with head and neck sarcomas. Otolaryngol Head Neck Surg 2014;151:976–83CrossRefGoogle Scholar
23Cockerill, CC, Daram, S, El-Nagger, AK, Weber, MD, Kupferman, ME. Primary sarcoma of the salivary glands: case series and literature review. Head Neck 2013;35:155–7CrossRefGoogle ScholarPubMed
24Mark, RJ, Tran, LM, Sercarz, J, Fu, YS, Calcaterra, TC, Juillard, GF. Angiosarcoma of the head and neck. The UCLA experience 1955 through 1990. Arch Otolaryngol Head Neck Surg 1993;119:973–8CrossRefGoogle ScholarPubMed
25Sarcoma Meta-analysis Collaboration. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet 1997;350:1647–54CrossRefGoogle Scholar
26Helliwell, TR, Giles, TE. Pathological aspects of the assessment of head and neck cancers: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 2016;130:S59–65CrossRefGoogle ScholarPubMed
27Singh, RP, Grimer, RJ, Bhujel, N, Carter, SR, Tillman, RM, Abudu, A. Adult head and neck soft tissue sarcomas: treatment and outcome. Sarcoma 2008:654987Google ScholarPubMed